Separation Technology Creamatocrit Plus, Catalog Number: 100-146

FDA Device Recall #Z-0905-2022 — Class II — March 16, 2022

Recall Summary

Recall Number Z-0905-2022
Classification Class II — Moderate risk
Date Initiated March 16, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Stanbio Laboratory, LP
Location Boerne, TX
Product Type Devices
Quantity 50

Product Description

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Reason for Recall

The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)

Distribution Pattern

US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN

Lot / Code Information

Sold between 2019 and 2021

Other Recalls from Stanbio Laboratory, LP

Recall # Classification Product Date
Z-0490-2024 Class II STAT-Site M BHB Test Strips, used with STAT-SIT... Oct 2, 2023
Z-2200-2021 Class III Beta-Hydroxybutyrate Reagent A - Enzyme (unlabe... Jul 12, 2021
Z-2201-2021 Class III Synchron CX/DX/LX Beta-Hydroxybutyrate . in vi... Jul 12, 2021
Z-2202-2021 Class III Cardinal Health Beta-Hydroxybutyrate . in vitr... Jul 12, 2021
Z-2199-2021 Class III Beta-Hydroxybutyrate LiquiColor. in vitro diag... Jul 12, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.